Update on male hormonal contraception
- PMID: 30899448
- PMCID: PMC6419257
- DOI: 10.1177/2042018819834846
Update on male hormonal contraception
Abstract
Despite increases in female contraceptive options, 40-45% of pregnancies across the world are still unplanned. While several effective female contraceptive methods have been developed, contraceptive choices for men are still limited to the male condom with its high failure rates and to vasectomies, which are invasive and not reliably reversible. Several studies have demonstrated a great interest among men and women for effective, reversible, and safe male contraceptive methods. Over the years, numerous studies have been performed to develop male hormonal and nonhormonal safe and effective contraceptives. A variety of new molecules are under development as oral or transdermal hormonal contraceptives for men demonstrating few side effects. In our overpopulated world, the development and commercialization of a male contraceptive method that will allow both men and women to take an active role in family planning is mandatory and further research on this topic is required.
Keywords: contraception; male contraception; male hormonal contraception.
Conflict of interest statement
Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.
Figures
Similar articles
-
Canadian Contraception Consensus (Part 2 of 4).J Obstet Gynaecol Can. 2015 Nov;37(11):1033-9. doi: 10.1016/s1701-2163(16)30054-8. J Obstet Gynaecol Can. 2015. PMID: 26629725 English, French.
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
-
Lessons from an audit of unplanned pregnancies.BMJ. 1988 Oct 8;297(6653):904-6. doi: 10.1136/bmj.297.6653.904. BMJ. 1988. PMID: 3140975 Free PMC article.
-
Male Contraception.Yale J Biol Med. 2020 Sep 30;93(4):603-613. eCollection 2020 Sep. Yale J Biol Med. 2020. PMID: 33005125 Free PMC article. Review.
-
Beyond the Condom: Frontiers in Male Contraception.Semin Reprod Med. 2016 May;34(3):183-90. doi: 10.1055/s-0036-1571435. Epub 2016 Mar 4. Semin Reprod Med. 2016. PMID: 26947703 Free PMC article. Review.
Cited by
-
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.Int J Mol Sci. 2022 Oct 8;23(19):11952. doi: 10.3390/ijms231911952. Int J Mol Sci. 2022. PMID: 36233256 Free PMC article. Review.
-
Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e835-47. doi: 10.1210/clinem/dgaa032. J Clin Endocrinol Metab. 2020. PMID: 31976519 Free PMC article. Clinical Trial.
-
Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.J Pharmacol Exp Ther. 2022 Sep;382(3):299-312. doi: 10.1124/jpet.122.001195. Epub 2022 Jul 2. J Pharmacol Exp Ther. 2022. PMID: 35779861 Free PMC article.
-
Male Hormonal Contraception-Current Stage of Knowledge.J Clin Med. 2025 Mar 23;14(7):2188. doi: 10.3390/jcm14072188. J Clin Med. 2025. PMID: 40217642 Free PMC article. Review.
-
Role of testis‑specific serine kinase 1B in undiagnosed male infertility.Mol Med Rep. 2022 Jun;25(6):204. doi: 10.3892/mmr.2022.12720. Epub 2022 Apr 29. Mol Med Rep. 2022. PMID: 35485285 Free PMC article.
References
-
- Wigginton B, Harris ML, Loxton D, et al. Who takes responsibility for contraception, according to young Australian women? Sex Reprod Healthc 2018; 15: 2–9. - PubMed
-
- Ilani N, Swerdloff RS, Wang C. Male hormonal contraception: potential risks and benefits. Rev Endocr Metab Disord 2011; 12: 107–117. - PubMed
Publication types
LinkOut - more resources
Full Text Sources